Progyny
Publicly traded fertility, family building, and women's health benefits platform serving employers and health plans, expanding into pregnancy, postpartum, and menopause.
New York, NY
2008
NASDAQ: PGNY
Employer Benefits, Commercial Insurance
What They Do
Progyny (NASDAQ: PGNY) provides employer-sponsored fertility and family-building benefits, pairing members with dedicated Patient Care Advocates and a curated specialist network. Historically the company was tightly focused on fertility and related family-building services, but it has broadened into pregnancy, postpartum, and menopause programs for global employers. The company’s revenue still comes from employer and health-plan contracts rather than direct consumer payments, which makes payer mix clearer than at many private fertility peers. As a public company, Progyny also offers more operating disclosure than most of the category.
Competitive Position
Progyny is the dominant employer-sponsored fertility benefits platform, trusted by leading Fortune 500 companies. The expansion into pregnancy, postpartum, and menopause creates direct overlap with the maternal health space tracked by PHD. Progyny competes with carrot-fertility and kindbody on fertility benefits, and now increasingly with maven-clinic on the broader women's health continuum. The ŌURA partnership and Amazon Health Benefits Connector integration signal a platform strategy that could make Progyny a central hub for employer-sponsored maternal-pediatric health navigation.